Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working
Elections
Archived
•
September 30, 2026
•
9 views
Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.
Source: NYT Politics | https://rss.nytimes.com/services/xml/rss/nyt/Politics.xml - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!


